Vertex Pharmaceuticals Incorporated VRTX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.26% | 23.02% | 16.86% | 8.05% | -3.64% |
| Total Receivables | 18.73% | 12.72% | 10.58% | 27.55% | 11.18% |
| Inventory | 38.02% | 17.73% | 29.93% | 39.94% | 50.66% |
| Prepaid Expenses | 5.41% | 12.60% | 15.66% | 60.32% | 58.31% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 534.90% | 475.81% | -21.41% | -43.29% | 41.90% |
| Total Current Assets | 10.57% | 20.29% | 17.20% | 16.72% | 7.81% |
|
|
|||||
| Total Current Assets | 10.57% | 20.29% | 17.20% | 16.72% | 7.81% |
| Net Property, Plant & Equipment | 10.34% | 25.63% | 25.02% | 19.28% | 20.01% |
| Long-term Investments | 122.74% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 122.74% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 1,881.81% | -5.21% | -5.15% | -48.64% | -48.32% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -19.72% | 12.29% | 18.23% | 24.11% | 22.60% |
| Total Assets | 31.67% | 14.09% | 15.75% | 13.80% | 11.79% |
|
|
|||||
| Total Accounts Payable | 12.44% | -2.89% | 9.96% | 11.79% | 6.19% |
| Total Accrued Expenses | -10.47% | -2.80% | 1.10% | 7.67% | 12.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -10.29% | -- |
| Total Finance Division Other Current Liabilities | -33.64% | -22.57% | 5.36% | 12.48% | 54.16% |
| Total Other Current Liabilities | -33.64% | -22.57% | 5.36% | 12.48% | 54.16% |
| Total Current Liabilities | 11.73% | -4.84% | 2.57% | 8.32% | 12.64% |
|
|
|||||
| Total Current Liabilities | 11.73% | -4.84% | 2.57% | 8.32% | 12.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 8.01% | 29.47% | 20.46% | 17.86% | 7.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.44% | 5.39% | 31.88% | 28.94% | 32.15% |
| Total Liabilities | 56.81% | 4.58% | 11.56% | 13.94% | 14.13% |
|
|
|||||
| Common Stock & APIC | -10.15% | -24.74% | -23.15% | -23.27% | -27.41% |
| Retained Earnings | 32.14% | 39.03% | 42.31% | 41.15% | 42.27% |
| Treasury Stock & Other | 188.68% | 147.97% | -63.58% | -112.44% | -323.96% |
| Total Common Equity | 20.72% | 17.89% | 17.37% | 13.75% | 10.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.72% | 17.89% | 17.37% | 13.75% | 10.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.72% | 17.89% | 17.37% | 13.75% | 10.80% |
|
|
|||||